Monopar Therapeutics, Inc. (MNPR)
114.11
-0.27
(-0.24%)
USD |
NASDAQ |
Sep 09, 14:39
Monopar Therapeutics Market Cap : 765.93M for Sept. 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 767.74M |
| September 04, 2026 | 789.09M |
| September 03, 2026 | 795.73M |
| September 02, 2026 | 780.49M |
| September 01, 2026 | 789.15M |
| August 31, 2026 | 751.30M |
| August 28, 2026 | 751.03M |
| August 27, 2026 | 764.79M |
| August 26, 2026 | 763.31M |
| August 25, 2026 | 743.85M |
| August 24, 2026 | 747.47M |
| August 21, 2026 | 723.04M |
| August 20, 2026 | 744.25M |
| August 19, 2026 | 831.24M |
| August 18, 2026 | 799.09M |
| August 17, 2026 | 781.90M |
| August 14, 2026 | 758.75M |
| August 13, 2026 | 741.09M |
| August 12, 2026 | 771.23M |
| August 11, 2026 | 768.28M |
| August 10, 2026 | 780.96M |
| August 07, 2026 | 800.16M |
| August 06, 2026 | 805.30M |
| August 05, 2026 | 798.73M |
| August 04, 2026 | 793.58M |
| Date | Value |
|---|---|
| August 03, 2026 | 747.89M |
| July 31, 2026 | 725.85M |
| July 30, 2026 | 768.12M |
| July 29, 2026 | 719.65M |
| July 28, 2026 | 730.80M |
| July 27, 2026 | 739.11M |
| July 24, 2026 | 736.03M |
| July 23, 2026 | 708.09M |
| July 22, 2026 | 753.51M |
| July 21, 2026 | 760.82M |
| July 20, 2026 | 709.43M |
| July 17, 2026 | 744.40M |
| July 16, 2026 | 726.99M |
| July 15, 2026 | 728.13M |
| July 14, 2026 | 668.50M |
| July 13, 2026 | 692.22M |
| July 10, 2026 | 714.12M |
| July 09, 2026 | 700.06M |
| July 08, 2026 | 665.02M |
| July 07, 2026 | 637.89M |
| July 06, 2026 | 650.62M |
| July 02, 2026 | 655.10M |
| July 01, 2026 | 636.62M |
| June 30, 2026 | 620.27M |
| June 29, 2026 | 633.47M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 296.18M |
| Amgen, Inc. | 211.84B |
| Anika Therapeutics, Inc. | 281.04M |
| BioCryst Pharmaceuticals, Inc. | 2.336B |
| Imunon, Inc. | 7.185M |
Market Cap Related Metrics
| Price to Book Value | 5.853 |
| Price | 114.11 |
| Earnings Yield | -2.05% |